Idiopathic Pulmonary Fibrosis
📧 Sign up to get email alerts when something new happens for Idiopathic Pulmonary Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-01Clinical Trial Update: Effect of Intrapulmonary Percussion Ventilation on Deposition of Inhaled Aerosols in Idiopathic Pulmonary Fibrosis [NA]
A completed clinical trial evaluated whether intrapulmonary percussion ventilation changes the deposition of inhaled aerosols in idiopathic …
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: This Study Tests Different Doses of BI 1015550 in Patients With Idiopathic Pulmonary Fibrosis (IPF). The Study Tests How BI 1015550 is Taken up by the Body and How Well it is Tolerated. [Phase 1]
This Phase 1 trial evaluates different doses of BI 1015550 in idiopathic pulmonary fibrosis, focusing on pharmacokinetics and tolerability.
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: A Multiple Ascending Doses (MAD) Study of PMG1015 in Idiopathic Pulmonary Fibrosis Subjects [Phase 1]
A Phase 1 MAD (multiple ascending dose) study of PMG1015 in idiopathic pulmonary fibrosis has completed.
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: A Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GNS-3545 in Healthy Participants [Phase 1]
A Phase 1 trial to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of GNS-3545 in healthy participants; the study i…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Telerehabilitation in Patients With Idiopathic Pulmonary Fibrosis [NA]
This entry notes that a clinical trial evaluating telerehabilitation for idiopathic pulmonary fibrosis is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: SB17170 Phase 2 Trial in IPF Patients [Phase 2]
SPARK Biopharma is conducting a Phase 2 trial of SB17170 in patients with idiopathic pulmonary fibrosis and the study is currently recruitin…
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
Clinical trial update indicating ongoing collection of airway, blood, and/or urine specimens from participants for research studies.
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 clinical trial evaluating oral INS018_055 for idiopathic pulmonary fibrosis is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)
A clinical trial at the University of Pittsburgh is investigating genetic polymorphisms associated with idiopathic pulmonary fibrosis.
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 trial evaluating the efficacy and safety of Orvepitant for chronic cough in idiopathic pulmonary fibrosis; study completed and resul…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis [Phase 2]
A Phase 2 clinical trial investigating zinc and nicotinamide riboside for idiopathic pulmonary fibrosis is currently recruiting. The sponsor…
-
CLINICAL_TRIALS trial_result · 2025-10-30Clinical Trial Update: Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF [Phase 2]
Phase 2 clinical trial update for the oral agent GRI-0621 in idiopathic pulmonary fibrosis reports biomarker modulation and inhibition of NK…
-
CLINICAL_TRIALS research · 2025-10-30Clinical Trial Update: Microarray Analysis of Gene Expression in Idiopathic Pulmonary Fibrosis (IPF)
This clinical trial update reports microarray analysis of gene expression in idiopathic pulmonary fibrosis.
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)
This clinical trial update outlines ongoing recruitment for a study examining genomic and proteomic factors associated with disease progress…
-
CLINICAL_TRIALS research · 2025-10-16Clinical Trial Update: LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
Phase 2 clinical trial of LYT-100 for idiopathic pulmonary fibrosis is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Study of ARO-MMP7 Inhalation Solution in Healthy Subjects and Patients With Idiopathic Pulmonary Fibrosis [Phase 1, Phase 2]
The document reports the completion of Phase 1 and Phase 2 trials of ARO-MMP7 Inhalation Solution in healthy subjects and patients with Idio…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis [Phase 2]
This document provides an update on a Phase 2 trial of TTI-101 in participants with idiopathic pulmonary fibrosis, indicating the study has …
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: Imaging Evaluation of PLN-74809 in Participants With IPF (PLN-74809) [Phase 2]
Imaging-based results from a Phase 2 study evaluating PLN-74809 in participants with idiopathic pulmonary fibrosis.
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: A Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Immunogenicity of HuL001 [Phase 1]
Phase 1 study evaluating safety, tolerability, pharmacokinetics, and immunogenicity of HuL001 in idiopathic pulmonary fibrosis has completed…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Interstitial Lung Disease Research Unit Biobank
A clinical trial update for an Interstitial Lung Disease Research Unit Biobank at University of Kansas Medical Center; the study is currentl…
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Escalation Phase I Clinical Study to Assess the Safety, Pharmacokinetics, and Immunogenicity of HLX6018 in Healthy Subjects [Phase 1]
This document reports the completion of a Phase 1, randomized, double-blind, placebo-controlled, single-dose escalation study to assess the …
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: To Assess the Efficacy of the Investigational Products Compared to Placebo in Participants With IPF [Phase 2]
A Phase 2 trial evaluating the efficacy of the investigational product(s) versus placebo in idiopathic pulmonary fibrosis was terminated; re…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Motivational Interviewing Program on the Self-Care in Idiopathic Pulmonary Fibrosis [NA]
This clinical trial update describes a motivational interviewing program to support self-care in idiopathic pulmonary fibrosis. The study is…
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: Sarcopenia in Patients With Idiopathic Pulmonary Fibrosis
A clinical trial evaluating sarcopenia in patients with idiopathic pulmonary fibrosis has completed.
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Disease-syndrome Characteristics of IPF
A clinical trial update describing the disease-syndrome characteristics of idiopathic pulmonary fibrosis (IPF), with the trial currently not…